← Open Payments lookup

JANE HAYES: Open Payments

NPI 1891384962 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$581 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $581

Food & beverage: $581
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$169
Otsuka America Pharmaceutical, Inc.9$162
E.R. Squibb & Sons, L.L.C.2$46
Teva Pharmaceuticals USA, Inc.2$33
Supernus Pharmaceuticals, Inc.1$30
ABBVIE INC.1$22
Corium, LLC2$21
Otsuka Pharmaceutical Development & Commercialization, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Lundbeck LLC1$15

Products named: INGREZZA, REXULTI, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, Qelbree, VRAYLAR, Azstarys.

Industry payments across TX — which companies pay providers there.